Renske Goedemans

1.9k citations

16 papers · 1.5k indexed · h-index 15

Immunology top 5%
- Immunotherapy and Immune Responses 6
- Immune cells in cancer 3
- Immune Cell Function and Interaction 3
Oncology top 5%
- Cancer Immunotherapy and Biomarkers 8
- Cytokine Signaling Pathways and Interactions 3
- CAR-T cell therapy research 2
Otorhinolaryngology top 5%
- Head and Neck Cancer Studies 3
Cancer Research top 10%
Reproductive Medicine top 10%
Genetics
- Virus-based gene therapy research 3

Co-authors: Sjoerd H. van der Burg Marij J.P. Welters Moniek Heusinkveld Arko Gorter Peggy J. de Vos van Steenwijk Tamara H. Ramwadhdoebé Thorbald van Hall Judith R. Kroep
Cited by: Immunology Oncology Otorhinolaryngology
Journals: Nature Communications (1 paper)The Journal of Immunology (1 paper)Cancer Research (2 papers)
Partner nations: Netherlands United States Italy

In The Last Decade

Renske Goedemans

16 papers receiving 1.5k citations

Peers

Countries citing papers authored by Renske Goedemans

Since Specialization

Citations

This map shows the geographic impact of Renske Goedemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renske Goedemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renske Goedemans more than expected).

Fields of papers citing papers by Renske Goedemans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renske Goedemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renske Goedemans. The network helps show where Renske Goedemans may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Renske Goedemans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Renske Goedemans Line = papers co-authored together Renske Goedemans links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Intratumoral HPV16-Specific T Cells Constitute a Type I–Oriented Tumor Microenvironment to Improve Survival in HPV16-Driven Oropharyngeal Cancer Clinical Cancer Research ·Marij J.P. Welters,Wenbo Ma,Saskia J. Santegoets,Renske Goedemans,Ilina Ehsan,Ekaterina S. Jordanova,Vanessa J. van Ham,Vincent van Unen,Frits Koning,Sylvia I. van Egmond,Pornpimol Charoentong,Zlatko Trajanoski,Lilly-Ann van der Velden,Sjoerd H. van der Burg	2017	122
2	Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFNγ- and TNFα-Mediated Antiproliferative Effects and Necroptosis Frontiers in Immunology ·Wenbo Ma,Bart Tummers,Edith M.G. van Esch,Renske Goedemans,Cornelis J.M. Melief,Craig Meyers,Judith M. Boer,Sjoerd H. van der Burg	2016	26
3	Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer Cancer Immunology Immunotherapy ·Mariëtte I.E. van Poelgeest,Valeria Visconti,Zohara Aghai,Vanessa J. van Ham,Moniek Heusinkveld,Maarten L. Zandvliet,A. Rob P.M. Valentijn,Renske Goedemans,Caroline E. van der Minne,Els M.E. Verdegaal,J. Baptist Trimbos,Sjoerd H. van der Burg,Marij J.P. Welters	2016	23
4	TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients Oncotarget ·Gijs G. Zom,Marij J.P. Welters,Nikki M. Loof,Renske Goedemans,Sinéad M. Lougheed,Rob Valentijn,Maarten L. Zandvliet,Nico J. Meeuwenoord,Cornelis J.M. Melief,Tanja D. de Gruijl,Gijsbert A. van der Marel,Dmitri V. Filippov,Ferry Ossendorp,Sjoerd H. van der Burg	2016	40
5	A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency Cancer Immunology Immunotherapy ·Simone Punt,Emilie A. C. Dronkers,Marij J.P. Welters,Renske Goedemans,Senada Koljenović,Elisabeth Bloemena,Peter J.F. Snijders,Arko Gorter,Sjoerd H. van der Burg,Robert J. Baatenburg de Jong,Ekaterina S. Jordanova	2016	80
6	A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer Annals of Oncology ·E. M. Dijkgraaf,Saskia J. Santegoets,A.K.L. Reyners,Renske Goedemans,Maartje C.A. Wouters,Gemma G. Kenter,Arien R. van Erkel,Mariëtte I.E. van Poelgeest,Hans W. Nijman,Jacobus J. M. van der Hoeven,Marij J.P. Welters,Sjoerd H. van der Burg,Judith R. Kroep	2015	163
7	The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation Nature Communications ·Bart Tummers,Renske Goedemans,Laetitia P.L. Pelascini,Ekaterina S. Jordanova,Edith M.G. van Esch,Craig Meyers,Cornelis J.M. Melief,Judith M. Boer,Sjoerd H. van der Burg	2015	62
8	A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer Oncotarget ·Eveline M. Dijkgraaf,Saskia J. Santegoets,A.K.L. Reyners,Renske Goedemans,Hans W. Nijman,Mariëtte I.E. van Poelgeest,Arien R. van Erkel,Vincent T.H.B.M. Smit,Toos Daemen,Jacobus J. M. van der Hoeven,Cornelis J.M. Melief,Marij J.P. Welters,Judith R. Kroep,Sjoerd H. van der Burg	2015	62
9	CD40-Mediated Amplification of Local Immunity by Epithelial Cells Is Impaired by HPV Journal of Investigative Dermatology ·Bart Tummers,Renske Goedemans,Veena Jha,Craig Meyers,Cornelis J.M. Melief,Sjoerd H. van der Burg,Judith M. Boer	2014	12
10	Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment Cancer Research ·Eveline M. Dijkgraaf,Moniek Heusinkveld,Bart Tummers,Lisa T.C. Vogelpoel,Renske Goedemans,Veena Jha,J.W.R. Nortier,Marij J.P. Welters,Judith R. Kroep,Sjoerd H. van der Burg	2013	286
11	Tumor‐infiltrating CD14‐positive myeloid cells and CD8‐positive T‐cells prolong survival in patients with cervical carcinoma International Journal of Cancer ·Peggy J. de Vos van Steenwijk,Tamara H. Ramwadhdoebé,Renske Goedemans,Elien M. Doorduijn,J. J. van Ham,Arko Gorter,Thorbald van Hall,Marieke L. Kuijjer,Mariëtte I.E. van Poelgeest,Sjoerd H. van der Burg,Ekaterina S. Jordanova	2013	106
12	Systemic and local human papillomavirus 16‐specific T‐cell immunity in patients with head and neck cancer International Journal of Cancer ·Moniek Heusinkveld,Renske Goedemans,Robert J.P. Briët,Hans Gelderblom,J.W.R. Nortier,Arko Gorter,Vincent T.H.B.M. Smit,Antonius P. M. Langeveld,Jeroen C. Jansen,Sjoerd H. van der Burg	2011	80
13	M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells The Journal of Immunology ·Moniek Heusinkveld,Peggy J. de Vos van Steenwijk,Renske Goedemans,Tamara H. Ramwadhdoebé,Arko Gorter,Marij J.P. Welters,Thorbald van Hall,Sjoerd H. van der Burg	2011	310
14	An Unexpectedly Large Polyclonal Repertoire of HPV-Specific T Cells Is Poised for Action in Patients with Cervical Cancer Cancer Research ·Peggy J. de Vos van Steenwijk,Moniek Heusinkveld,Tamara H. Ramwadhdoebé,Margriet J. Löwik,Jeanette M. van der Hulst,Renske Goedemans,Sytse J. Piersma,Gemma G. Kenter,Sjoerd H. van der Burg	2010	70
15	Influenza matrix 1‐specific human CD4⁺FOXP3⁺ and FOXP3⁻ regulatory T cells can be detected long after viral clearance European Journal of Immunology ·Sytse J. Piersma,Jeanette M. van der Hulst,Kitty M.C. Kwappenberg,Renske Goedemans,Caroline E. van der Minne,Sjoerd H. van der Burg	2010	15
16	Hsp70 expression and induction as a readout for detection of immune modulatory components in food Cell Stress and Chaperones ·Lotte Wieten,Ruurd van der Zee,Renske Goedemans,Jeroen Sijtsma,Mauro Serafini,Nicolette H. Lubsen,Willem van Eden,Femke Broere	2009	29

About Renske Goedemans

Renske Goedemans is a scholar working on Otorhinolaryngology, Oncology and Immunology, having authored 16 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (6 papers), Virus-based gene therapy research (3 papers), Immune cells in cancer (3 papers), Head and Neck Cancer Studies (3 papers), Immune Cell Function and Interaction (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Immunology (919 citations), Oncology (795 citations) and Otorhinolaryngology (114 citations). Renske Goedemans has collaborated with scholars based in Netherlands, United States and Italy. Frequent co-authors include Sjoerd H. van der Burg, Marij J.P. Welters, Moniek Heusinkveld, Arko Gorter, Peggy J. de Vos van Steenwijk, Tamara H. Ramwadhdoebé, Thorbald van Hall, Judith R. Kroep, Bart Tummers and J.W.R. Nortier. Their work appears in journals such as Nature Communications, The Journal of Immunology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact